To establish the impact of increased sEng levels in estrogen-induced cholestasis in mice treated with labetalol, we used transgenic mice overexpressing human soluble endoglin (hsEng), a recognized model of preeclampsia, and their wild-type (WT) littermates, as control. The gene discussed is ENG; the disease is preeclampsia.